Heart Failure NYHA Class IV
31
6
7
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
31%
4 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (31)
CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
Sustaining Home Heart Failure Palliative Care in Rural Appalachia
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
Hemodynamic-GUIDEd Management of Heart Failure
REDUCED FUNCTIONALITY AND KINESIOPHOBIA IN PATIENTS WITH HEART FAILURE: USE OF ALTERNATIVE THERAPEUTIC STRATEGIES
Association Between the Sit-To-Stand Test and the Prognosis of Patients With Heart Failure
Mid-Q Response Study
A Study to Improve Physician-Youth Communication and Medical Decision Making
Whole Heart Radiotherapy for End-stage Heart Failure
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone
Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients
Family Palliative and End-of-Life Care for Advanced Heart Failure
Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes
Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)
Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
Exergaming in Advanced HF With Multiple Chronic Conditions Prior to LVAD Implantation or Heart Transplant
Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF